Abstracts
Showing 852 abstracts.
Citation
Sharon Appelbaum Nachman, M.D., Lin-Ye Song, Ph.D., Mark J. Abzug, M.D. Safety and Immunogenicity of pneumococcal conjugate vaccine (PCV) and routine pediatric immunizations in HIV infected on HAART (PACTG 1024). Presented at: 43rd Intersci Conf on Antimicrobial Agents & Chemotherapy.Conference
43rd Intersci Conf on Antimicrobial Agents & Chemotherapy
Study
P1024
Citation
John S. Lambert, M.D. Safety and Immunogenicity of Recombinant Envelope HIV Vaccines in Asymptomatic HIV Infected Children.Citation
Coleen Cunningham, Ulla Buchholz, Petronella Muresan, Elizabeth McFarland, Cindy Luongo, Peter Collins, Bhavin Thumar, Betty Schappell, Devasena Gnanashanmugam, George Siberry, Vivian Rexroad, Ruth Karron. Safety and Immunogenicity of the Recombinant Live-Attenuated Respiratory syncytial Virus Vaccine RSV cps2 in RSV-seronegative Infants and Children. Presented at: IDWeek 2015.Conference
IDWeek 2015
Study
P1114
Citation
Coleen Cunningham, Ulla Buchholz, Petronella Muresan, Elizabeth McFarland, Cindy Luongo, Peter Collins, Bhavin Thumar, Betty Schappell, Devasena Gnanashanmugam, George Siberry, Vivian Rexroad, Ruth Karron. Safety and immunogenicity of the recombinant live-attenuated respiratory syncytial virus vaccine RSV cps2 in RSV-seronegative infants and children. Presented at: ID Week 2015.Conference
ID Week 2015
Citation
Safety and Immunogenicity of Two Doses of Monovalent Pandemic H1N1 (pH1N1) Influenza Vaccine in HIV-Infected Pregnant Women. Presented at: 48th Annual Meeting of Infectious Diseases Society of Amercia.Conference
48th Annual Meeting of Infectious Diseases Society of Amercia
Study
P1086
Citation
John S. Lambert, M.D. Safety and Pharmacokinetics of Hyperimmune HIV Immunoglobulin (HIVIG) in HIV+ Pregnant Women and Newborns.Citation
Moherndran Archary, Jorge Pinto, Edmund Capparelli, Edward P. Acosta, S. Y. Amy Cheung, Thomas N. Kakuda, Ellen M. Townley, Jack Moye, Ryan Milligan, Rachel Scheckter, Gaerolwe Masheto, Pradthana Ounchanum, Linda Aurpibul, Lee Fairlie , CRAYON Study Team. Safety and pharmacokinetics of long-acting cabotegravir and rilpivirine in children between 20-40 kg.Citation
Mo Archary, Jorge Pinto, Edmund Caparelli, Ed Acosta, Amy Cheung, Herta Crauwels, Ellen Townley, Jack Moye, Mark Giganti, Rachel Scheckter, Barb Heckman, Cristina Hofer, Mrinmayee Dhar, Sisinyana Ruth Mathiba, CRAYON/IMPAACT 2036 Study Team. Safety and pharmacokinetics of long-acting cabotegravir and rilpivirine in young children 10 to 40 kg. Presented at: CROI 2026; 2026 Feb 24.Conference
CROI 2026
Study
IMPAACT 2036
Citation
EJ MacFarland, CK Cunningham, EV Capparelli, P Muresan, E Smith, C Perlowski, L Morrison, P Morgan, AB McDermott, R Hazra, JR Mascola, B Graham. Safety and pharmacokinetics of monoclonal antibody VRC01LS in HIV-exposed newborns. Presented at: CROI 2019; 2019 Mar 05.Conference
CROI 2019
Study
P1112